Screener
Edgewise Therapeutics, Inc. EWTX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Edgewise Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 8:09 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056713
FAQ
- What is Edgewise Therapeutics, Inc.'s current ratio?
- Edgewise Therapeutics, Inc. (EWTX) reported current ratio of 22.6× in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s current ratio changed year-over-year?
- Edgewise Therapeutics, Inc.'s current ratio increased by 7.7% year-over-year, from 21× to 22.6×.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s current ratio has grown at a -7.8% compound annual growth rate (CAGR), from 29.9× to 19.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Edgewise Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude